drugset / Trial / NCT03324581
The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder
RandomizedParallel-groupTriple-blindTreatment
Summary
A trial to assess the safety and efficacy of OPC-64005 in the treatment of adult attention-deficit/hyperactivity disorder.
Timeline
- Start
- 2017-11-09
- Primary completion
- 2018-10-31
- Completion
- 2018-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atomoxetine | Other / unclassified | 80 mg | Oral |
| Subject | OPC-64005 | Unknown | 30 mg | Oral |